Related Experiment Video
Updated: Mar 14, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
4.1K
Vitamin B6 modulates CD8+ T cell antitumor responses.
1Sanquin Blood Supply Foundation, Department of Research, 1066 CX Amsterdam, the Netherlands; Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.
Developmental Cell
|March 12, 2026
Summary
Pyridoxal phosphate (PLP), the active form of vitamin B6, boosts the immune system's ability to clear tumors. PLP supports CD8+ T cells by keeping them in a stem-like state, which is crucial for effective cancer immunotherapy.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- CD8+ T cells are critical for tumor clearance.
- Maintaining T cell stemness is vital for sustained anti-tumor immunity.
- Vitamin B6 metabolism plays a role in immune cell function.
Purpose of the Study:
- To investigate the role of pyridoxal phosphate (PLP) in CD8+ T cell-mediated tumor clearance.
- To elucidate the molecular mechanisms by which PLP affects CD8+ T cell function.
- To explore the implications of PLP for cancer immunotherapy.
Main Methods:
- In vivo tumor models.
- Flow cytometry and single-cell RNA sequencing.
- Analysis of T cell populations and function.
Main Results:
- PLP enhances CD8+ T cell-dependent tumor clearance.
- PLP maintains CD8+ T cells in a stemness-like state.
- PLP inhibits the nuclear translocation of BACH2 in CD8+ T cells.
Conclusions:
- The active form of vitamin B6, PLP, is a key factor in anti-tumor immunity.
- Targeting PLP or its downstream pathways may represent a novel strategy for cancer immunotherapy.
- Understanding PLP's role in T cell stemness provides insights into improving cancer treatments.
More Related Videos
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
7.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:22T Cell Activation and Clonal Selection
17.0K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
17.0K
01:24B Cell Activation and Differentiation
17.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.8K
01:29Immune Response Against Viral Pathogens
2.4K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K